Sign in Create account

KDL Biotech Ltd.

BSE: 532291
₹2.14
▼ -0.11 (-4.89%)
March 16, 2015 · BSE · bse_bhavcopy
Quality
—/100
Data unavailable
Valuation
—/100
Data unavailable
Momentum
68/100
Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
Data unavailable.
PE (TTM)
Data unavailable.
Price to Book
Data unavailable.
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
20.2
Relative return vs Sector, qtr %
Data unavailable.
Free Cash Flow
Data unavailable.
EPS Growth (YoY)
Data unavailable.
Net Profit Growth (TTM)
Data unavailable.
Operating Revenue Growth (TTM)
Data unavailable.
Profit Growth (YoY)
Data unavailable.
Revenue Growth (YoY)
Data unavailable.
Current Ratio
Data unavailable (needs a filed half-yearly balance sheet).
Debt to Equity
Data unavailable (needs a filed half-yearly balance sheet).
Interest Coverage
Data unavailable.
Net Margin
Data unavailable.
Operating Margin (EBIT)
Data unavailable.
Operating Margin (TTM)
Data unavailable.
Return on Assets
Data unavailable.
Return on Capital Employed
Data unavailable (needs a filed half-yearly balance sheet).
Return on Equity
Data unavailable (needs a filed half-yearly balance sheet).

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Value and momentum

1 of 4 met
  • No Momentum score is Bullish (70 or more)
  • Yes Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-4.9%
Low 2.1400 · High 2.1400
1W return
-4.9%
Low 2.1400 · High 2.1400
1M return
13.2%
Low 1.9000 · High 2.2500
52W return
20.2%
Low 1.6200 · High 4.0000
Lifetime High ₹27.4500 (Jan. 2, 2008)
Lifetime Low ₹1.6200 (Dec. 22, 2014)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish3
Bearish3
5D
2.1
10D
2.0
20D
2.0
50D
2.2
100D
2.3
200D
2.3

Delivery and volume

Day avg. delivery
100.0%
Week avg. delivery
100.0%
Month avg. delivery
100.0%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

2.14
Pivot
First resistance2.14
Second resistance2.14
Third resistance2.14
First support2.14
Second support2.14
Third support2.14
Day RSI53.8
Day MFI25.9
Day MACD-0.04
Day MACD signal-0.13

Beta

1M—
3M—
1Y0.05
3Y0.41

Price change analysis

↑ 13.2%
Over 1 Month
LowHigh
1.902.25
↑ 28.1%
Over 3 Months
LowHigh
1.622.25
↑ 7.0%
Over 6 Months
LowHigh
1.622.25
↑ 20.2%
Over 1 Year
LowHigh
1.624.00
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Financials

View full financials, peers & valuation multiples →

Data unavailable.

Shareholding pattern / Ownership

Data unavailable.

Full shareholding pattern →

Deals (Bulk & Block)

All 10 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
19 Mar 2013 GANDIV INVESTMENT PVT. LTD. Bulk Sell 210,383 2.2300 BSE
19 Mar 2013 HARDIK BHARAT PATEL Bulk Buy 210,383 2.2300 BSE
1 Jun 2011 RAKESHKUMAR MANGILAL RANKA (HUF) Bulk Buy 207,417 9.0200 BSE
1 Jun 2011 RAKESHKUMAR MANGILAL RANKA (HUF) Bulk Sell 263,917 9.0900 BSE
25 Jul 2008 UNIMARK REMEDIES LIMITED Block Buy 1,743,192 9.4000 BSE
25 Jul 2008 SARVAMANGAL MERCANTILE CO LTD Block Sell 1,743,192 9.4000 BSE
25 Jul 2008 SARVAMANGAL MERCANTILE CO LTD Bulk Sell 1,743,192 9.4000 BSE
7 Sep 2007 ZIELLE VENTURES PRIVATE L Bulk Sell 85,000 13.5700 BSE
9 Aug 2007 ZIELLE VENTURES PRIVATE L Bulk Buy 100,000 16.4400 BSE
16 Mar 2006 RAJESH RAMU DEORA Bulk Buy 89,471 14.9500 BSE

All bulk and block deals →

Corporate Actions

Full history (8 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
—NAME_CHANGEName changed from Kopran Drugs Ltd. to KDL Biotech Ltd.
21 Sep 2012OTHERAnnual General Meeting
22 Sep 2011OTHERAnnual General Meeting
5 Aug 2010OTHERAnnual General Meeting
19 Mar 2009OTHERAnnual General Meeting

All corporate actions →

Corporate Announcements

All 24 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
18 May 2018 Delisting Members of the Exchange are hereby notified that in terms of Regulation 22(6) of the Securities and Exchange Board of India (Delisting of Equity Shares) Regulations, 2009, Section 21A of the Securities Contract (Regulations) Act, 1956, Rule 21(2) b of Securities Contract (Regulations) Rules, 1957 , it has been decided to delist (withdraw the admission to dealings in) equity shares of the KDL Biotech Limited w.e.f. May 30, 2018 as per Chapter V of SEBI (Delisting of Equity Shares) Regulations, 2009.
24 Jan 2018 Public Notice - Compulsory Delisting Members of the Exchange are hereby informed that the Exchange on January 18, 2018 has issued public notice in the newspaper for�� proposed compulsory delisting of equity shares of the company, in term of Regulation 22 (3) of SEBI (Delisting of Equity shares) Regulation, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/common/CorporateAnnouncements).
18 Feb 2015 Financial Result Updates KDL Biotech Limited has submitted to the exchange the standalone financial results for the period ended 31-Dec-2014.
13 Feb 2015 Financial Result Updates KDL Biotech Limited has submitted to the exchange the standalone financial results for the period ended 31-Dec-2013.
2 Dec 2013 Suspension of Trading Members of the Exchange are hereby informed that trading in the equity shares of KDL Biotech Limited will be suspended w.e.f. December 10, 2013 (i.e. closing hours of trading on December 09, 2013) as the company has failed to respond satisfactorily to the notice of the Exchange for non-compliance with the provisions of listing agreement.
26 Sep 2013 Updates KDL Biotech Limited has informed the Exchange that the Registrar of Companies, Maharashtra, Mumbai vide his Order dated March 13, 2013, has granted extension of time for holding Annual General Meeting of the Company for the Accounting period ended March 31, 2013 (3 months) upto December 30, 2013.
3 Jun 2013 Financial Result Updates KDL Biotech Limited has submitted to the Exchange the Standalone Financial Results for the period ended March 31,2013.
9 May 2013 Strikes/Lockouts/Disturbances KDL Biotech Limited has informed the Exchange that the worker of the Company is on strike since April 29, 2013. Due to this all the production activities are stand still.
6 May 2013 Cessation KDL Biotech Limited has informed the Exchange that : (1) Mr. Yogendra Chauhan has ceases to be director of the company w.e.f. April 18, 2013; (2) Mr. Manish Bojwani has ceases to be Company Secretary of the company w.e.f April 20, 2013.
19 Apr 2013 Change in Director(s) KDL Biotech Limited has informed the Exchange that Pursuant to the provisions of Clause 30 of the Listing Agreement with the Stock Exchanges, we would like to intimate that 1. Dr. Avantika Varma has been appointed as Additional Director of the Company w.e.f 17th April, 2013 and 2. Dr. Tushar Srivastava has ceased to be the Director of the Company w.e.f. 18th April, 2013. Kindly acknowledge receipt of the same.

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

Data unavailable.

Weaknesses

Data unavailable.

Opportunities

Data unavailable.

Threats

Data unavailable.

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about KDL Biotech Ltd.

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.